Literature DB >> 27277710

Cardiovascular implanted electronic devices in people towards the end of life, during cardiopulmonary resuscitation and after death: guidance from the Resuscitation Council (UK), British Cardiovascular Society and National Council for Palliative Care.

David Pitcher1, Jasmeet Soar2, Karen Hogg3, Nicholas Linker4, Simon Chapman5, James M Beattie6, Sue Jones7, Robert George8, Janet McComb9, James Glancy10, Gordon Patterson11, Sheila Turner12, Susan Hampshire13, Andrew Lockey14, Tracey Baker15, Sarah Mitchell16.   

Abstract

The Resuscitation Council (UK), the British Cardiovascular Society (including the British Heart Rhythm Society and the British Society for Heart Failure) and the National Council for Palliative Care recognise the importance of providing clear and consistent guidance on management of cardiovascular implanted electronic devices (CIEDs) towards the end of life, during cardiorespiratory arrest and after death. This document has been developed to provide guidance for the full range of healthcare professionals who may encounter people with CIEDs in the situations described and for healthcare managers and commissioners. The authors recognise that some patients and people close to patients may also wish to refer to this document. It is intended as an initial step to help to ensure that people who have CIEDs, or are considering implantation of one, receive explanation of and understand the practical implications and decisions that this entails; to promote a good standard of care and service provision for people in the UK with CIEDs in the circumstances described; to offer relevant ethical and legal guidance on this topic; to offer guidance on the delivery of services in relation to deactivation of CIEDs where appropriate; to offer guidance on whether any special measures are needed when a person with a CIED receives cardiopulmonary resuscitation; and to offer guidance on the actions needed when a person with a CIED dies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2016        PMID: 27277710     DOI: 10.1136/heartjnl-2016-309721

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

Review 1.  Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients.

Authors:  Mina M Benjamin; Christine A Sorkness
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  Entresto therapy effectively protects heart and lung against transverse aortic constriction induced cardiopulmonary syndrome injury in rat.

Authors:  Hung-I Lu; Meng-Shen Tong; Kuan-Hung Chen; Fan-Yen Lee; John Y Chiang; Sheng-Ying Chung; Pei-Hsun Sung; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.

Authors:  Samantha M McEvedy; Jan Cameron; Eugene Lugg; Jennifer Miller; Chris Haedtke; Muna Hammash; Martha J Biddle; Kyoung Suk Lee; Justin A Mariani; Chantal F Ski; David R Thompson; Misook Lee Chung; Debra K Moser
Journal:  Palliat Med       Date:  2017-07-05       Impact factor: 4.762

4.  Recommendations for the Post-Mortem Management of Cardiac Implantable Electronic Devices.

Authors:  Júlio César de Oliveira; Alexsandro Alves Fagundes; Ricardo Alkmim-Teixeira; José Mário Baggio Junior; Luciana Armaganijan; Andre d'Avila; Eduardo B Saad; Veridiana Silva de Andrade; Luis Gustavo Belo de Moraes; Ricardo Kuniyoshi; André Gustavo da Silva Rezende; Mauricio Pimentel; Thiago da Rocha Rodrigues; Helio Lima de Brito Junior; Elenir Nadalin; Cristiano Faria Pisani; Elerson Arfelli; Fatima Dumas Cintra; Carlos Antonio Abunader Kalil; Sissy Lara de Melo; Priscila Moreno Sperling Cannavan
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

Review 5.  Electrical Storm in Patients with Implantable Cardioverter-defibrillators: A Practical Overview.

Authors:  Daniele Muser; Jackson J Liang; Pasquale Santangeli
Journal:  J Innov Card Rhythm Manag       Date:  2017-10-15

6.  Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.

Authors:  Rik Stoevelaar; Arianne Brinkman-Stoppelenburg; Anne Geert van Driel; Dominic Amj Theuns; Rohit E Bhagwandien; Rozemarijn L van Bruchem-Visser; Ineke E Lokker; Agnes van der Heide; Judith Ac Rietjens
Journal:  Eur J Cardiovasc Nurs       Date:  2019-04-17       Impact factor: 3.908

7.  Geriatric issues in patients with or being considered for implanted cardiac rhythm devices: a case-based review.

Authors:  Michael A Chen
Journal:  J Geriatr Cardiol       Date:  2020-11-28       Impact factor: 3.327

Review 8.  [Adult advanced life support].

Authors:  Jasmeet Soar; Bernd W Böttiger; Pierre Carli; Keith Couper; Charles D Deakin; Therese Djärv; Carsten Lott; Theresa Olasveengen; Peter Paal; Tommaso Pellis; Gavin D Perkins; Claudio Sandroni; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-08       Impact factor: 0.826

9.  'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.

Authors:  Holly Standing; Richard G Thomson; Darren Flynn; Julian Hughes; Kerry Joyce; Trudie Lobban; Stephen Lord; Dan D Matlock; Janet M McComb; Paul Paes; Chris Wilkinson; Catherine Exley
Journal:  BMJ Open       Date:  2021-07-06       Impact factor: 2.692

10.  Improving rates of implantable cardioverter defibrillator deactivation in end-of-life care.

Authors:  M R Javaid; Suzanne Squirrell; Fahad Farooqi
Journal:  BMJ Open Qual       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.